Compare AstraZeneca plc (AZN) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Remitly Global Inc — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Remitly Global Inc trades at $23.73 (market cap $4.97B). The key difference: AstraZeneca plc is far larger — about 49.9× Remitly Global Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals.
| AZN | RELY | |
|---|---|---|
Market Cap | $248.14B | $4.97B |
Sector | Health | Technology |
52-Week High | $209.48 | $25.93 |
52-Week Low | $147.06 | $12.20 |
Enterprise Value | $275.41B | $4.33B |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
